GLP-1 receptor agonists show promise in treating hidradenitis suppurativa, offering significant symptom relief and improved ...

A multicenter French study led by Rennes University Hospital reports potential benefits of glucagon-like peptide-1 receptor ...

In this retrospective study, patients who started a GLP-1 agonist experienced significant declines in hidradenitis ...

Discover a study validating a disease-specific quality-of-life tool for hidradenitis suppurativa, confirming its reliability, ...

Panelists discuss the critical importance of early biologic therapy initiation in hidradenitis suppurativa to prevent irreversible tissue damage, reduce disease burden, and overcome socioeconomic and ...

Hidradenitis Suppurativa Market Size was USD ~1,400 million in the 7MM in 2023. Management involves antibiotics, surgery, and ...

Hidradenitis suppurativa is usually a clinical diagnosis, meaning doctors can determine if you have it after a physical exam. "When patients come in, we can usually tell right away whether they ...

Incyte Corporation (($CC:INCY.CUR)) announced an update on their ongoing clinical study. Study Overview: Incyte Corporation is conducting a Phase ...

Hidradenitis suppurativa patients face higher depression and anxiety risks, but biologic treatments may reduce these mental ...

1. Hidradenitis suppurativa can be emotionally exhausting. Living with a condition that affects every aspect of your life, including how you dress or your ability to work out, can feel burdensome ...

Topline data from Phase 2 LOTUS trial of AVTX-009 for the treatment of hidradenitis suppurativa expected mid-2026Rita Jain, M.D. appointed to Board of DirectorsCash and short-term investments of ...